Deep search
Profile Picture
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • 2024 Election
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past 24 hours
    • Any time
    • Past hour
    • Past 7 days
    • Past 30 days
  • Most recent
    • Best match
Pharmabiz6h
Eupraxia Pharma reports positive data from RESOLVE phase 1b/2a trial of EP-104GI for treatment of eosinophilic esophagitis
Victoria, British Columbia Thursday, November 14, 2024, 18:00 Hrs [IST] ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Florida sues FEMA officials
The Onion buys Infowars
Republicans win the House
Named grand marshal
Declines WH invitation
Judge blocks name change
FBI raids Coplan's home
Ban on executives upheld
Gaetz resigns from Congress
Lawyers seek to quit case
Bitcoin rises above $90K
Israel accused of war crimes
Teen guilty of swatting calls
Largest coral ever recorded
Remains ID'd after 82 years
Pulled from lunch program
China hacked telecom firms
Global increase in diabetes
Briefly detained at airport
2,400+ Cybertrucks recalled
Threatened by LSU student?
Trump, Biden meet at WH
Russia attacks Kyiv
Freevee to shut down
Wants Trump docs case paused
Notre Dame set to reopen
Wins GOP nod for speaker
Gabbard picked as DNI

Related topics

European Union
Sanofi
Dupilumab
Feedback
© 2024 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy